Puneet Singh, MD FACS (@puneetsinghmd) 's Twitter Profile
Puneet Singh, MD FACS

@puneetsinghmd

Assistant Professor, Breast Surgical Oncology & Assoc. PD, BSO Fellowship @MDAndersonNews. Alum of @UChiPritzker, @uchicagosurgery & @WUSTL. Tweets are my own.

ID: 879730039339847684

calendar_today27-06-2017 15:56:00

4,4K Tweet

3,3K Followers

2,2K Following

Justin Mecham (@thejustinmecham) 's Twitter Profile Photo

Most people listen to respond, not to understand: True empathy goes beyond listening. It's about truly understanding another person's experience. Follow me and join my free newsletter for more! Please repost to help others out there! ♻️

Most people listen to respond, not to understand:

True empathy goes beyond listening.

It's about truly understanding another person's experience.

Follow me and join my free newsletter for more!

Please repost to help others out there! ♻️
Dana-Farber’s Breast Oncology Center (@dfci_breastonc) 's Twitter Profile Photo

Dr. Adrienne Waks (Ada Waks) offered a great overview of treatment options for small tumors in early #BreastCancer in the #SABCS24 educational session on Optimizing Early HER2 Positive Breast Cancer Treatment.

Dr. Adrienne Waks (<a href="/adawaksmd/">Ada Waks</a>) offered a great overview of treatment options for small tumors in early #BreastCancer in the #SABCS24 educational session on Optimizing Early HER2 Positive Breast Cancer Treatment.
Puneet Singh, MD FACS (@puneetsinghmd) 's Twitter Profile Photo

Robert Hills presents meta-analysis of 3 studies of > 1000 patients on immediate vs delayed surgery for early stage breast cancer. Immediate surgery reduces local recurrence & distant recurrence though occurs over longer follow up. Also reduced breast cancer mortality #SABCS24

Robert Hills presents meta-analysis of 3 studies of &gt; 1000 patients on immediate vs delayed surgery for early stage breast cancer. Immediate  surgery reduces local recurrence &amp; distant recurrence though occurs over longer follow up. Also reduced breast cancer mortality #SABCS24
Translational Breast Cancer Research Consortium (@thetbcrc) 's Twitter Profile Photo

.Ada Waks presents RCT TBCRC052/MARGOT at #SABCS24 showing margetuximab (TMP) no statistically sig improved pCR rate vs THP for mostly cT2N0 disease though 10% higher numerically. Did not differ by HR status. Both well tolerated regimens Dana-Farber’s Breast Oncology Center

.<a href="/adawaksmd/">Ada Waks</a> presents RCT TBCRC052/MARGOT at #SABCS24 showing margetuximab (TMP) no statistically sig improved pCR rate vs THP for mostly cT2N0 disease though 10% higher numerically. Did not differ by HR status. Both well tolerated regimens <a href="/DFCI_BreastOnc/">Dana-Farber’s Breast Oncology Center</a>
Puneet Singh, MD FACS (@puneetsinghmd) 's Twitter Profile Photo

.Mafalda Oliveira presents SOLTI VALENTINE: neoadj randomized study of HER3-DXd, an ADC, in high-risk early stage HR+ breast cancer - comparable pCR rate to chemo however still low rates of pCR #SABCS24

.<a href="/MOliveira_MD/">Mafalda Oliveira</a> presents SOLTI VALENTINE: neoadj randomized study of HER3-DXd, an ADC, in high-risk early stage HR+ breast cancer - comparable pCR rate to chemo however still low rates of pCR #SABCS24
Puneet Singh, MD FACS (@puneetsinghmd) 's Twitter Profile Photo

Dr. Sarah McLaughlin nicely summarizes lymphedema surgical prevention & management strategies. There is a significant need but data are mixed especially for prevention. Like many I eagerly await the Alliance ARM trial results. #SABCS24

Dr. Sarah McLaughlin nicely summarizes lymphedema surgical prevention &amp; management strategies. There is a significant need but data are mixed especially for prevention. Like many I eagerly await the Alliance ARM trial results. #SABCS24
Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo

Intriguing results from the #neoHIP randomized phase 2 trial presented by Heather McArthur, MD, MPH, FASCO. The addition of pembro to neoadjuvant THP for stage II-III HER2+ BC improved pCR rate (delta 18%) with no new safety signals. Looking forward to seeing the impact of these results on EFS. #bcsm

Intriguing results from the #neoHIP randomized phase 2 trial presented by <a href="/hmcarthur/">Heather McArthur, MD, MPH, FASCO</a>. The addition of pembro to neoadjuvant THP for stage II-III HER2+ BC improved pCR rate (delta 18%) with no new safety signals. Looking forward to seeing the impact of these results on EFS. #bcsm